Breaking: A COVID-19 vaccination site in Colorado had to shut down operations for the day after thirteen people had severe reactions to the Johnson & Johnson vaccine on Wednesday.
Officials at this time decided to not disclose the severity of the reactions that were suffered from the ‘experimental’ vaccine. The reactions were only reported by less than 1 percent of the more than 1,700 people given shots in Commerce City, as reported by The Denver Gazette.
The vaccination site was placed in effect and sponsored by the state and Centura Health. Thousands of these sites have been erected almost overnight where hundreds of thousands have received the vaccine by driving through these make-shift camps. The site shut down before more than 600 other people with appointments were unable to get vaccinated due to the adverse reactions.
"We followed our protocols and in an abundance of caution, made the decision — in partnership with the state — to pause operations for the remainder of the day," Centura Health officials said in the statement obtained by the newspaper.
People with appointments who were turned away will be rescheduled to receive their shots at a different site on Sunday.
The Biden administration has made promises to deliver millions of these vaccines to Americans by the end of Summer. Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky has made a remark in an Instagram Live conversation on ABC News that they anticipate all schools to be fully in person in September 2021.
"We should anticipate, come September 2021, that schools should be full-fledged in person and all of our children back in the classroom," the CDC director told ABC News Chief Medical Correspondent Dr. Jennifer Ashton.
When asked when she expected children to become eligible for vaccination, Walensky answered by mid-May. She said that all Americans should anticipate this return to school in September whether children have been vaccinated or not.
"We can vaccinate teachers, we can test, there's so much we can do," she said.
Pfizer recently released promising data indicating its vaccine is safe and effective for children ages 12 to 15.